Department of Radiation Oncology, University of California, San Francisco, California 94143-1708, USA.
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):25-30. doi: 10.1016/j.ijrobp.2010.01.044. Epub 2010 Jun 18.
Resection margin status is one of the most significant factors for local recurrence in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery with or without radiation. However, its impact on chest wall recurrence in patients treated with mastectomy is unknown. The purpose of this study was to determine chest wall recurrence rates in women with DCIS and close (<5 mm) or positive mastectomy margins in order to evaluate the potential role of radiation therapy.
Between 1985 and 2005, 193 women underwent mastectomy for DCIS. Fifty-five patients had a close final margin, and 4 patients had a positive final margin. Axillary surgery was performed in 17 patients. Median follow-up was 8 years. Formal pathology review was conducted to measure and verify margin status. Nuclear grade, architectural pattern, and presence or absence of necrosis was recorded.
Median pathologic size of the DCIS in the mastectomy specimen was 4.5 cm. Twenty-two patients had DCIS of >5 cm or diffuse disease. Median width of the close final margin was 2 mm. Nineteen patients had margins of <1 mm. One of these 59 patients experienced a chest wall recurrence with regional adenopathy, followed by distant metastases 2 years following skin-sparing mastectomy. The DCIS was high-grade, 4 cm, with a 5-mm deep margin. A second patient developed an invasive cancer in the chest wall 20 years after her mastectomy for DCIS. This cancer was considered a new primary site arising in residual breast tissue.
The risk of chest wall recurrence in this series of patients is 1.7% for all patients and 3.3% for high-grade DCIS. One out of 20 (5%) patients undergoing skin sparing or total skin-sparing mastectomy experienced a chest wall recurrence. This risk of a chest wall recurrence appears sufficiently low not to warrant a recommendation for postmastectomy radiation therapy for patients with margins of <5 mm. There were too few patients with positive margins to draw any firm conclusions.
在接受保乳手术联合或不联合放疗的导管原位癌(DCIS)患者中,切缘状态是局部复发的最重要因素之一。然而,其对接受乳房切除术的患者胸壁复发的影响尚不清楚。本研究旨在确定 DCIS 女性患者切缘接近(<5mm)或阳性时的胸壁复发率,以评估放疗的潜在作用。
1985 年至 2005 年间,193 例女性因 DCIS 行乳房切除术。55 例患者切缘接近,4 例患者切缘阳性。17 例患者行腋窝手术。中位随访时间为 8 年。进行了正式的病理复查以测量和验证切缘状态。记录核分级、结构模式以及有无坏死。
乳房切除标本中 DCIS 的中位病理大小为 4.5cm。22 例患者的 DCIS 大于 5cm 或弥漫性病变。接近的最终切缘的中位宽度为 2mm。19 例患者的切缘<1mm。这 59 例患者中有 1 例出现胸壁复发,伴有区域淋巴结转移,继而行保乳手术后 2 年发生远处转移。该患者的 DCIS 为高级别,4cm,深切缘为 5mm。第二位患者在因 DCIS 行乳房切除术 20 年后发生胸壁浸润性癌。该癌症被认为是起源于残余乳腺组织的新原发性肿瘤。
在本系列患者中,所有患者的胸壁复发风险为 1.7%,高级别 DCIS 的胸壁复发风险为 3.3%。行保乳或全乳保留皮肤的乳房切除术的 20 例患者中有 1 例(5%)发生胸壁复发。对于切缘<5mm 的患者,胸壁复发的风险似乎足够低,不需要推荐行乳房切除术后放疗。由于阳性切缘的患者太少,无法得出任何明确的结论。